scholarly journals The Carry-Over Effect of Competition in Task-Sharing: Evidence from the Joint Simon Task

PLoS ONE ◽  
2014 ◽  
Vol 9 (6) ◽  
pp. e97991 ◽  
Author(s):  
Cristina Iani ◽  
Filomena Anelli ◽  
Roberto Nicoletti ◽  
Sandro Rubichi
2019 ◽  
Vol 34 (4) ◽  
pp. 455-459
Author(s):  
Ryota HIYOSHI ◽  
Kazunobu FUKUHARA ◽  
Takahiro HIGUCHI

Diabetologia ◽  
1994 ◽  
Vol 37 (9) ◽  
pp. 855-862 ◽  
Author(s):  
S. Pampfer ◽  
Y. D. Wuu ◽  
I. Vanderheyden ◽  
R. De Hertogh

2008 ◽  
Vol 8 (12) ◽  
pp. 1622-1625 ◽  
Author(s):  
Giorgio Ciprandi ◽  
Maria Pia Sormani ◽  
Gilberto Filaci ◽  
Daniela Fenoglio

1953 ◽  
Vol 32 (5) ◽  
pp. 754-762 ◽  
Author(s):  
S.J. Slinger ◽  
W.F. Pepper ◽  
A.M. Morphet ◽  
E.V. Evans
Keyword(s):  

PEDIATRICS ◽  
1983 ◽  
Vol 71 (4) ◽  
pp. 524-530
Author(s):  
Thomas E. Liston ◽  
Col William S. Foshee ◽  
Maj Wayne D. Pierson

Sulfisoxazole, 75 mg/kg/d in two divided doses for 3 months, was administered in a double-blind placebo crossover study to 35 children aged 6 months to 5 years who had frequent recurring episodes of otitis media. There was a 40% reduction in the rate of otitis media among patients receiving sulfisoxazole compared with those receiving placebo (0.25 v 0.42 episode per patient-month) which did not depend on age, sex, season, or several other factors. Using a randomized order, among patients who received placebo first, there was a 64% reduction on sulfisoxazole therapy compared with placebo (0.20 v 0.56 episode per patient-month). In this subgroup, there was significant improvement in eustachian tube function according to serial tympanograms. In the patients who received sulfisoxazole first, the rate of acute otitis remained low on placebo (0.28 v 0.30 episode per patient-month), and tympanogram patterns continued to improve after discontinuation of the active drug. These differences suggest a carry-over effect from the benefits of chemoprophylaxis. There was no significant difference in the species or sensitivity patterns of bacteria isolated from patients receiving sulfisoxazole or placebo. Sulfisoxazole chemoprophylaxis appears to be safe and effective in significantly reducing episodes of otitis media and improving tympanogram patterns.


Mathematics ◽  
2019 ◽  
Vol 7 (12) ◽  
pp. 1179
Author(s):  
Miltiadis S. Chalikias

The optimal cross-over experimental designs are derived in experiments with two treatments, four periods, and an experimental unit. The results are given for the values n = 0mod4, 1mod4, 2mod4 and 3mod4. The criterion being the minimization of the variance of the estimated carry over effect.


2001 ◽  
Author(s):  
Anna K. Chernakova ◽  
Alan J. Fan
Keyword(s):  

1965 ◽  
Vol 29 (2) ◽  
pp. 46-53 ◽  
Author(s):  
Donald S. Tull

Most advertisers believe there is a carry-over effect of advertising. What evidence is available, and what does it indicate about the relationships of sales to advertising? The author of this article presents a case study, and examines other evidence bearing on this question. He also constructs models involving repeat purchasing and impression cumulation as underlying reasons for a carry-over effect.


Sign in / Sign up

Export Citation Format

Share Document